Related Experiment Video
Updated: Mar 31, 2026

09:36
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
9.5K
Gene Interference with Morpholinos in a Gold Nanoparticle-Based Delivery Platform in Rat PC12 Cells
Journal of Biomedical Nanotechnology
|October 30, 2015
Summary
Researchers developed gold nanocomplexes for efficient gene knockdown of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor 1 (PAC1R). This significantly reduced PAC1R protein levels, impacting PACAP
Area of Science:
- Neuroscience
- Molecular Biology
- Biotechnology
Background:
- Pituitary adenylate cyclase-activating polypeptide (PACAP) plays a role in neural cell differentiation.
- The PACAP receptor 1 (PAC1R) is crucial for mediating PACAP's effects.
- Developing targeted methods to study PACAP/PAC1R signaling is essential.
Purpose of the Study:
- To demonstrate the efficiency of gene knockdown of PAC1R using novel gold nanocomplexes.
- To investigate the impact of PAC1R gene knockdown on PACAP-induced neurite outgrowth in PC12 cells.
- To establish a new tool for studying PACAP's neurotropic effects.
Main Methods:
- Gold nanoparticle-cholera toxin B conjugates loaded with morpholinos (MOs) were synthesized.
- Nanocomplexes were delivered into PC12 cells via lipid raft-dependent endocytosis.
- UV light triggered the release of antisense MO to knock down PAC1R mRNA.
Main Results:
- Maximal PAC1R gene knockdown efficiency of 65% ± 12 reduction in protein level was achieved within 24 hours.
- Reduced PAC1R impaired PC12 cell responsiveness to PACAP.
- Neurite outgrowth decreased to 10% ± 8 and 11% ± 9 after PACAP exposure in knockdown cells.
Conclusions:
- Gold nanocomplexes provide an efficient method for PAC1R gene knockdown.
- PAC1R is critical for PACAP-mediated neurite outgrowth and neural differentiation in PC12 cells.
- This approach enhances understanding of PACAP's neurotropic roles.
Related Concept Videos
Experimental RNAi
8.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
RNA Interference
28.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K

